METTL3 and colorectal carcinoma: To validate whether FMR1 promotes CRC cell proliferation and metastasis by recognizing m6A modification site, we constructed stable CRC cell lines with METTL3 overexpression and stable CRC cell lines with METTL3 overexpression and FMR1 inhibition.